Screening for major depressive episodes in Japanese patients with epilepsy: Validation and translation of the Japanese version of Neurological Disorders Depression Inventory for Epilepsy (NDDI-E)

Tadokoro, Yukari; Oshima, Tomohiro; Fukuchi, Toshihiko; Kanner, Andrés M.; Kanemoto, Kousuke

doi:10.1016/j.yebeh.2012.06.015

Cited by 48 publications

(29 citation statements)

References 15 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Most studies validating other versions of the NDDI-E showed analogous results (e.g., the Italian version showed a prevalence of 24.2% [23] and the Spanish version, 20% [24]). Only the Japanese version showed a relatively low level of prevalence of 8% [21]. Such difference may be due to differences in the nature of the targeted participants.…”

Section: Discussionmentioning

confidence: 90%

“…The cutoff score for the original version (i.e., the English version) of the NDDI-E was N 15 [16] which was subsequently tested to be suitable in Brazilian and Greek versions [19,20], while studies in Italy, Germany, and Spain recommended a different cutoff score of N13 [22][23][24]. However, in Asian countries, the cutoff scores varied greatly, with N11 in the Korean version [25] and N16 in the Japanese version [21]. The ROC curve analysis indicated a cutoff score that was fairly low among all the versions.…”

Section: Discussionmentioning

confidence: 99%

“…It has been translated and validated in several languages. The original English version recommended a cutoff score of N15 for screening MDD, while versions in other languages suggested different cutoff scores that range from 11 to 16 [19][20][21][22][23][24][25].…”

Section: Introductionmentioning

confidence: 99%

See 2 more Smart Citations

Validation of the Chinese version of the Neurological Disorders Depression Inventory for Epilepsy (C-NDDI-E) in West China

Tong

Lan

et al. 2015

Epilepsy & Behavior

Self Cite

View full text Add to dashboard Cite

Section: Discussionmentioning

confidence: 90%

Section: Discussionmentioning

confidence: 99%

See 1 more Smart Citation

Validation of the Chinese version of the Neurological Disorders Depression Inventory for Epilepsy (C-NDDI-E) in West China

Tong

Lan

et al. 2015

Epilepsy & Behavior

Self Cite

View full text Add to dashboard Cite

“…The neurological disorders depression inventory for epilepsy (NDDI-E), now validated in several languages, is a reliable tool that is easy to use in the neurology outpatient setting as it takes only a few minutes to complete. [36][37][38] A score of >15 has a 90 per cent specificity and 81 per cent sensitivity for diagnosis of major depression. 39 If a patient has a high score then they will require more in-depth assessment of the depressive symptoms.…”

Section: How Does Depression Present In Epilepsy?mentioning

confidence: 99%

What do we know about depression in people with epilepsy?

Muzerengi¹,

Moor²

2013

Prog Neurol Psychiatry

View full text Add to dashboard Cite

Depression is the commonest comorbid psychiatric condition in epilepsy. 1 The relationship between epilepsy and depression was described as far back as 400 BC by Hippocrates. 2 Studies have consistently shown a higher prevalence rate of depression in patients with epilepsy compared with the general population. 3 In a Canadian population-based study, authors reported an estimated lifetime prevalence of mood disorders of 24.4 per cent in individuals with epilepsy, compared to 13.2 per cent in those without. The lifetime prevalence of major depression was 17.4 per cent in those with epilepsy compared to 10.7 per cent in people without epilepsy. 3 Other psychiatric disorders including anxiety, bipolar disorder and suicidal ideation were also more common in the epilepsy group. Higher prevalence rates of up to 48 per cent have been reported in tertiary centre-based studies. 3 These patients were more likely to have refractory epilepsy and temporal lobe epilepsy and hence have an increased risk of comorbid psychiatric disorders. 3,4 Despite its high prevalence in epilepsy, depression remains poorly recognised and undertreated by health professionals. 5 In a study to assess the effect of sertraline on seizure frequency in 100 patients with epilepsy and depression, 60 per cent had a one-year history of psychiatric symptoms, but only 35 per cent of these had been offered or requested treatment within six months of symptom onset. 5 Gilliam et al. found that in the majority of patients, depression is missed because clinicians do not enquire about depressive symptoms. 6 The impact of depression needs to be highlighted. Depression and low mood have been shown to be a strong predictor of health-related quality of life. [6][7][8] Even in people with well controlled seizures, depression remains the main determinant of quality of life. 9 A higher suicide rate has also been reported in people with epilepsy compared with their healthy counterparts. Lifetime prevalence of suicidal ideation in individuals with epilepsy was 25 per cent and 13.3 per cent in healthy controls. 3 Furthermore, the presence of psychiatric illness, and more so depression, has been shown to be associated with poor response to antiepileptic treatment. 10 Hitiris et al. followed up 780 patients with new-onset epilepsy over a median period of 79 months. Patients with epilepsy and psychiatric illnesses were less likely to be seizure free than those with epilepsy without depression. 10 Similar results were found in individuals undergoing epilepsy surgery for temporal lobe epilepsy. Those who had a history of depression were less likely to be seizure or aura free compared with those with epilepsy and no psychiatric history. 11,12 These findings highlight the need for increased awareness of this common psychiatric symptom among clinicians .In this article, we discuss the risk factors, pathophysiology and treatment strategies for depression in epilepsy. What are the risk factors for depression in epilepsy?Several factors including gender, genetics, seizure type, ep...

show abstract

“…It takes 3 min to complete; a total score >15 is suggestive of a MDE with a sensitivity of 89% and a specificity of 90% 13 . Since its publication in 2006, there has been an interest in validating and translating this instrument to other languages, and up to now, validated versions of the NDDI‐E have become available in Portuguese, 14 Japanese, 15 Italian, 16 and Spanish from Spain 17 . In this article, we present the validation and translation of the NDDI‐E from the original English version into Spanish from Argentina.…”

mentioning

confidence: 99%

Screening of major depression in epilepsy: The Neurologic Depression Disorders Inventory in Epilepsy‐Spanish version (Argentina)

et al. 2014

View full text Add to dashboard Cite

SUMMARYObjectives: To validate and translate the English version of the Neurologic Depression Disorders Inventory in Epilepsy (NDDI-E) into Spanish as a screening instrument for major depressive episodes (MDE) for patients with epilepsy from Argentina and Uruguay. Methods: One hundred fifty-five consecutive outpatients with epilepsy participated in this study. The module of MDE of the MINI International Neuropsychiatric Instrument (MINI Plus version) was used as the gold standard against which the translated version of the NDDI-E was validated. Results: Among the 155 patients, 25 (16%) met Diagnostic and Statistical Manual, Fourth Edition (DSM-IV) criteria for MDE according to the MINI. With a total score of >15, The NDDI-E identified MDE with an 80% sensitivity, 90% specificity, 60% positive predictive value, and 95.5% negative predictive value. Significance: These data indicate that the Spanish version of the NDDI-E can reliably identify MDE in patients with epilepsy from Argentina and Uruguay.

show abstract

Screening for major depressive episodes in Japanese patients with epilepsy: Validation and translation of the Japanese version of Neurological Disorders Depression Inventory for Epilepsy (NDDI-E)

Cited by 48 publications

References 15 publications

Validation of the Chinese version of the Neurological Disorders Depression Inventory for Epilepsy (C-NDDI-E) in West China

Validation of the Chinese version of the Neurological Disorders Depression Inventory for Epilepsy (C-NDDI-E) in West China

What do we know about depression in people with epilepsy?

Screening of major depression in epilepsy: The Neurologic Depression Disorders Inventory in Epilepsy‐Spanish version (Argentina)

Contact Info

Product

Resources

About